Profilo
Hui Ju Chan is currently the Chairman at PharmaDax (Guangzhou), Inc., Empax Pharma (Foshan) Inc., and Director at PharmaDax USA, Inc., Sandex Group Ltd., Fortune Tower Group Corp., and Shengqun Pharmaceutical Co., Ltd.
Additionally, Ms. Chan has been the President at PharmaDax Inc. since 2012.
Ms. Chan's education includes an undergraduate degree from National Taipei University of Technology and an MBA from Soochow University.
Posizioni attive di Hui Ju Chan
| Società | Posizione | Inizio |
|---|---|---|
| PHARMADAX INC. | Presidente | - |
| PharmaDax (Guangzhou), Inc. | Presidente | - |
| PharmaDax USA, Inc. | Direttore/Membro del Consiglio | - |
| Sandex Group Ltd. | Direttore/Membro del Consiglio | - |
| Fortune Tower Group Corp. | Direttore/Membro del Consiglio | - |
| Empax Pharma (Foshan) Inc. | Presidente | - |
| Shengqun Pharmaceutical Co., Ltd. | Direttore/Membro del Consiglio | - |
Formazione di Hui Ju Chan
| Soochow University /Taiwan/ | Masters Business Admin |
| National Taipei University of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
| PharmaDax (Guangzhou), Inc. | |
| PharmaDax USA, Inc. | |
| Sandex Group Ltd. | |
| Fortune Tower Group Corp. | |
| Empax Pharma (Foshan) Inc. | |
| Shengqun Pharmaceutical Co., Ltd. |
- Borsa valori
- Insiders
- Hui Ju Chan
